NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Clinical Informatics and Big Data > Genetic link discovered between circadian rhythms and mood disorders

Genetic link discovered between circadian rhythms and mood disorders

15 August 2018 · Listed under Clinical Informatics and Big Data

In the largest ever genetic study of circadian rest-activity cycles in humans, scientists at the University of Glasgow, supported by data from the NIHR oxford Biomedical Research Centre (BRC), have identified a possible genetic link between circadian disruption and mood disorders.

The new findings, published on 15 August in EBioMedicine, follow research published earlier this year in The Lancet Psychiatry which found that disrupted circadian rhythms were associated with increased risk of mood disorders, including major depression and bipolar disorder.

Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits. Circadian rhythms, which also occur in plants and animals, are fundamental for maintaining health in humans, particularly mental health and wellbeing.

The findings of this new study identified two areas of the human genome that may contain genetic variants that increase risk of disruption to rest-activity cycles.

The researchers found that one of these areas contained the gene Neurofascin, which binds to the protein product of a well-known candidate gene for bipolar disorder (Ankyrin G), suggesting a direct biological link between circadian disruption and severe mood disorder. Genetic loading for circadian disruption was also significantly associated with mood instability.

The team included Aiden Doherty, of the Oxford BRC’s Clinical Informatics and Big Data Theme, whose role involved deriving measures of activity from wrist-worn sensors distributed to over 100,000 UK Biobank participants. The BRC also provided support on the genetic analysis.

Read more about the study.

← BRC researcher to lead NIHR funding board
Research for better shared decision-making in knee surgery →

News

  • COVID-19 ‘matching service’ increased public involvement in research, HRA finds 20 January 2021
  • Classification system uncovers new information about ovarian cancers 18 January 2021
  • Ancient gene mutation found to cause rare hereditary condition 18 January 2021
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page